Shenhav Cohen

Dr. Shenhav Cohen

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2014 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
SCShenhav Cohen
Shenhav Cohen
JNJames Alexander Nathan
James Alexander Nathan
AGAlfred L. Goldberg
Alfred L. Goldberg

5 June 2017 in Nature
Verified
Journal Article
Open access
PDF file
EBElad Bassat
Elad Bassat
YMYara Eid Mutlak
Yara Eid Mutlak
AGAlex Genzelinakh
Alex Genzelinakh
ISIlya Y. Shadrin
Ilya Y. Shadrin
KUKfir Baruch Umansky
Kfir Baruch Umansky
ETEldad Tzahor
Eldad Tzahor
The adult mammalian heart is non-regenerative owing to the post-mitotic nature of cardiomyocytes. The neonatal mouse heart can regenerate, but only during the first week of life. Here we show that changes in the composition of the extracellular matrix during this week can affect cardiomyocyte growth and differentiation in mice. We identify agrin, a component of neonatal extracellular matrix, as required for the full regenerative capacity of neonatal mouse hearts. In vitro, recombinant agrin promotes the division of cardiomyocytes that are derived from mouse and human induced pluripotent stem cells through a mechanism that involves the disassembly of the dystrophin–glycoprotein complex, and Yap- and ERK-mediated signalling. In vivo, a single administration of agrin promotes cardiac regeneration in adult mice after myocardial infarction, although the degree of cardiomyocyte proliferation observed in this model suggests that there are additional therapeutic mechanisms. Together, our results uncover a new inducer of mammalian heart regeneration and highlight fundamental roles of the extracellular matrix in cardiac repair.

8 June 2009 in Journal of Cell Biology
Verified
Journal Article
Open access
SCShenhav Cohen
Shenhav Cohen
Jeffrey BraultJeffrey Brault
Jeffrey Brault
SGSteven P. Gygi
Steven P. Gygi
DGDavid J. Glass
David J. Glass
DVDavid M. Valenzuela
David M. Valenzuela
AGAlfred Goldberg
Alfred Goldberg
Loss of myofibrillar proteins is a hallmark of atrophying muscle. Expression of muscle RING-finger 1 (MuRF1), a ubiquitin ligase, is markedly induced during atrophy, and MuRF1 deletion attenuates muscle wasting. We generated mice expressing a Ring-deletion mutant MuRF1, which binds but cannot ubiquitylate substrates. Mass spectrometry of the bound proteins in denervated muscle identified many myofibrillar components. Upon denervation or fasting, atrophying muscles show a loss of myosin-binding protein C (MyBP-C) and myosin light chains 1 and 2 (MyLC1 and MyLC2) from the myofibril, before any measurable decrease in myosin heavy chain (MyHC). Their selective loss requires MuRF1. MyHC is protected from ubiquitylation in myofibrils by associated proteins, but eventually undergoes MuRF1-dependent degradation. In contrast, MuRF1 ubiquitylates MyBP-C, MyLC1, and MyLC2, even in myofibrils. Because these proteins stabilize the thick filament, their selective ubiquitylation may facilitate thick filament disassembly. However, the thin filament components decreased by a mechanism not requiring MuRF1.

20 August 2012 in Journal of Cell Biology
Verified
Journal Article
Open access
SCShenhav Cohen
Shenhav Cohen
BZBo Zhai
Bo Zhai
SGSteven P. Gygi
Steven P. Gygi
AGAlfred Goldberg
Alfred Goldberg
During muscle atrophy, myofibrillar proteins are degraded in an ordered process in which MuRF1 catalyzes ubiquitylation of thick filament components (Cohen et al. 2009. J. Cell Biol. http://dx.doi.org/10.1083/jcb.200901052). Here, we show that another ubiquitin ligase, Trim32, ubiquitylates thin filament (actin, tropomyosin, troponins) and Z-band (α-actinin) components and promotes their degradation. Down-regulation of Trim32 during fasting reduced fiber atrophy and the rapid loss of thin filaments. Desmin filaments were proposed to maintain the integrity of thin filaments. Accordingly, we find that the rapid destruction of thin filament proteins upon fasting was accompanied by increased phosphorylation of desmin filaments, which promoted desmin ubiquitylation by Trim32 and degradation. Reducing Trim32 levels prevented the loss of both desmin and thin filament proteins. Furthermore, overexpression of an inhibitor of desmin polymerization induced disassembly of desmin filaments and destruction of thin filament components. Thus, during fasting, desmin phosphorylation increases and enhances Trim32-mediated degradation of the desmin cytoskeleton, which appears to facilitate the breakdown of Z-bands and thin filaments.

7 April 2021 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
GAGiulio Agnetti
Giulio Agnetti
HHHarald Herrmann
Harald Herrmann
SCShenhav Cohen
Shenhav Cohen
Desmin is the primary intermediate filament (IF) of cardiac, skeletal, and smooth muscle. By linking the contractile myofibrils to the sarcolemma and cellular organelles, desmin IF contributes to muscle structural and cellular integrity, force transmission, and mitochondrial homeostasis. Mutations in desmin cause myofibril misalignment, mitochondrial dysfunction, and impaired mechanical integrity leading to cardiac and skeletal myopathies in humans, often characterized by the accumulation of protein aggregates. Recent evidence indicates that desmin filaments also regulate proteostasis and cell size. In skeletal muscle, changes in desmin filament dynamics can facilitate catabolic events as an adaptive response to a changing environment. In addition, post‐translational modifications of desmin and its misfolding in the heart have emerged as key determinants of homeostasis and disease. In this review, we provide an overview of the structural and cellular roles of desmin and propose new models for its novel functions in preserving the homeostasis of striated muscles.

5 March 2020 in EMBO Reports
Verified
Journal Article
Open access
PDF file
DGDana Goldbraikh
Dana Goldbraikh
DNDanielle Neufeld
Danielle Neufeld
YEYara Eid‐Mutlak
Yara Eid‐Mutlak
ILInbal Lasry
Inbal Lasry
JGJennifer E Gilda
Jennifer E Gilda
SCShenhav Cohen
Shenhav Cohen
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.